Market Overview:
The global granisetron HCl reagent market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing use of granisetron HCl reagents in research and medical applications. Additionally, the growing demand for minimally-invasive surgeries is also contributing to the growth of this market. However, factors such as high cost and limited availability are restraining the growth of this market. On the basis of type, the global granisetron HCl reagent market can be segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. Of these, min purity less than 98% held a major share in 2017 and is expected to continue its dominance during the forecast period. This can be attributed to its low cost as compared with other types of granisetron HCl reagents available in the market.
Product Definition:
A serotonin receptor antagonist used as an antiemetic. It is especially effective against vomiting induced by chemotherapy.
Min Purity Less Than 98%:
Min Purity Less Than 98% is a special category of chemicals that are used as building blocks for other compounds. They are also used in themselves, as they have several desirable properties such as low vapor pressure and boiling point. These products find application in various industries such as pharmaceuticals, research & development laboratories, analytical testing labs and more.
Min Purity 98%-99%:
Min Purity 98%-99% is a pharmaceutical-grade material and is used as granisetron HCl reagent. It contains 98.0%-99.0% of the active ingredient, which is used in the preparation of various medicines such as 5-HT3 receptor antagonists, buspirone,eslicarbazepine maleate, etc.
The global granisetron HCl reagent market size was valued at USD 35 million in 2016.
Application Insights:
Medical application of the drug accounted for the largest share in 2017. It is used as an antiemetic agent to prevent and treat nausea, vomiting and abdominal pain caused by various medical conditions, such as cancer chemotherapy, postoperative pain, diabetic gastroparesis and motion sickness. The drug is also used for palliative treatment of patients with advanced stages of cancer who are undergoing end-of-life care or have suffered from severe brain injuries.
The research segment is expected to expand at a CAGR of XX% over the forecast period owing to increasing R&D on new therapeutic applications involving different target molecules other than nausea and emesis. For instance; Parkinson¢â‚¬â„¢s disease which involves both neurological disorders (PD) & gastrointestinal motility (GID).
Regional Analysis:
North America dominated the global granisetron hcl reagent market in 2017. The presence of a large number of manufacturers coupled with high R&D investment by companies is expected to drive the regional demand over the forecast period. In addition, increasing cases of breast cancer and other gynecological malignancies are also expected to fuel growth over the next eight years.
Asia Pacific is anticipated to witness significant growth owing to rising healthcare expenditure and improving healthcare infrastructure in emerging countries such as China, India, South Korea & Japan (KSOJ). Moreover, growing awareness about early diagnosis among patients is further anticipated boost regional demand during the forecast period.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for Granisetron HCl Reagent market. According to the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths from cancer worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030. This will create a large demand for Granisetron HCl Reagent products, which will drive the market growth.
- Rising awareness about chemotherapy side effects: Chemotherapy is one of the most common treatments for cancer, but it often causes adverse side effects such as nausea and vomiting. As a result, patients are increasingly becoming aware of the benefits of using Granisetron HCl Reagent products to reduce these side effects, which will drive market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Granisetron HCl Reagent Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
TCI, Merck, Bio-Techne, BioVision, Cayman Chemical, Santa Cruz Biotechnology, Abcam, Selleck Chemicals, LGC, Biosynth Carbosynth, Shimadzu, SimSon Pharma, BOC Sciences, BioCrick BioTech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Granisetron HCl Reagent Market Report Segments:
The global Granisetron HCl Reagent market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- TCI
- Merck
- Bio-Techne
- BioVision
- Cayman Chemical
- Santa Cruz Biotechnology
- Abcam
- Selleck Chemicals
- LGC
- Biosynth Carbosynth
- Shimadzu
- SimSon Pharma
- BOC Sciences
- BioCrick BioTech
Highlights of The Granisetron HCl Reagent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Granisetron HCl Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Granisetron HCl Reagent is a medication that is used to treat nausea and vomiting. It works by blocking the nerve impulses that cause these symptoms.
Some of the key players operating in the granisetron hcl reagent market are TCI, Merck, Bio-Techne, BioVision, Cayman Chemical, Santa Cruz Biotechnology, Abcam, Selleck Chemicals, LGC, Biosynth Carbosynth, Shimadzu, SimSon Pharma, BOC Sciences, BioCrick BioTech.
The granisetron hcl reagent market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Granisetron HCl Reagent Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Granisetron HCl Reagent Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Granisetron HCl Reagent Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Granisetron HCl Reagent Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Granisetron HCl Reagent Market Size & Forecast, 2020-2028 4.5.1 Granisetron HCl Reagent Market Size and Y-o-Y Growth 4.5.2 Granisetron HCl Reagent Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Granisetron HCl Reagent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Granisetron HCl Reagent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Granisetron HCl Reagent Market: Competitive Dashboard
14.2 Global Granisetron HCl Reagent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 TCI
14.3.2 Merck
14.3.3 Bio-Techne
14.3.4 BioVision
14.3.5 Cayman Chemical
14.3.6 Santa Cruz Biotechnology
14.3.7 Abcam
14.3.8 Selleck Chemicals
14.3.9 LGC
14.3.10 Biosynth Carbosynth
14.3.11 Shimadzu
14.3.12 SimSon Pharma
14.3.13 BOC Sciences
14.3.14 BioCrick BioTech